series-a
Stage
2
Investors
About
PreComb develops a high-throughput, automated functional cancer profiling platform that uses patient-derived tumour samples to predict drug response and support oncology decision-making.
Explore PreComb's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.